De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Laurus Labs Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Laurus Labs heeft een totaal eigen vermogen van ₹41.2B en een totale schuld van ₹25.8B, wat de schuld-eigenvermogensverhouding op 62.6% brengt. De totale activa en totale passiva bedragen respectievelijk ₹83.9B en ₹42.7B. De EBIT Laurus Labs is ₹3.8B waardoor de rentedekking 2.2 is. Het heeft contanten en kortetermijnbeleggingen van ₹1.4B.
Belangrijke informatie
62.6%
Verhouding schuld/eigen vermogen
₹25.77b
Schuld
| Rente dekkingsratio | 2.2x |
| Contant | ₹1.42b |
| Aandelen | ₹41.16b |
| Totaal verplichtingen | ₹42.71b |
| Totaal activa | ₹83.87b |
Recente financiële gezondheidsupdates
Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 01
These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well
Jul 06Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 18Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?
Sep 09Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet
Jun 11Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Feb 26Recent updates
Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year
Jul 05Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues
Jul 03Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40
Apr 28Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jan 27Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 01Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year
Oct 22These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well
Jul 06Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20
Apr 30Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?
Dec 18Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 27Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?
Sep 09Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet
Jun 11Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Larger Dividend Than Last Year
May 02Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Feb 26With EPS Growth And More, Laurus Labs (NSE:LAURUSLABS) Is Interesting
Feb 11Does Laurus Labs (NSE:LAURUSLABS) Have A Healthy Balance Sheet?
Nov 26Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.80
Nov 13I Ran A Stock Scan For Earnings Growth And Laurus Labs (NSE:LAURUSLABS) Passed With Ease
Nov 12Laurus Labs (NSE:LAURUSLABS) Has Affirmed Its Dividend Of ₹0.80
Oct 30A Look At The Intrinsic Value Of Laurus Labs Limited (NSE:LAURUSLABS)
Oct 05Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?
Aug 10Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly
Jul 23Is Laurus Labs Limited (NSE:LAURUSLABS) Worth ₹547 Based On Its Intrinsic Value?
Jun 06We Think That There Are Issues Underlying Laurus Labs' (NSE:LAURUSLABS) Earnings
May 06Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?
May 05Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹38.3B ) LAURUSLABS } overtreffen de korte termijn passiva ( ₹31.1B ).
Langlopende schulden: De kortetermijnactiva LAURUSLABS ( ₹38.3B ) overtreffen de langetermijnschulden ( ₹11.6B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 59.2% ) LAURUSLABS wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van LAURUSLABS is de afgelopen 5 jaar gedaald van 66.5% naar 62.6%.
Schuldendekking: De schuld van LAURUSLABS wordt goed gedekt door de operationele kasstroom ( 25.8% ).
Rentedekking: De rentebetalingen van LAURUSLABS op haar schulden worden niet goed gedekt door EBIT ( 2.2 x dekking).